| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49702-266-63 | 49702-266 | HUMAN PRESCRIPTION DRUG | Cabenuva | cabotegravir and rilpivirine | KIT | 20250121 | N/A | NDA | NDA212888 | ViiV Healthcare Company | 1 KIT in 1 CARTON (49702-266-63) * 3 mL in 1 VIAL (49702-238-64) * 3 mL in 1 VIAL (49702-243-61) | |||
| 49702-253-15 | 49702-253 | HUMAN PRESCRIPTION DRUG | Cabenuva | cabotegravir and rilpivirine | KIT | 20210121 | N/A | NDA | NDA212888 | ViiV Healthcare Company | 1 KIT in 1 CARTON (49702-253-15) * 2 mL in 1 VIAL (49702-245-01) * 2 mL in 1 VIAL (49702-249-02) | |||
| 49702-240-15 | 49702-240 | HUMAN PRESCRIPTION DRUG | Cabenuva | cabotegravir and rilpivirine | KIT | 20210121 | N/A | NDA | NDA212888 | ViiV Healthcare Company | 1 KIT in 1 CARTON (49702-240-15) * 3 mL in 1 VIAL (49702-238-01) * 3 mL in 1 VIAL (49702-243-02) |